EU Court Cuts Big Pharma Fine Over Heart Drugs

While the French maker of medication to treat high blood pressure made illegal agreements with other pharmaceutical companies to keep a generic version of the drug off the market, the European General Court found abuse of dominant position hadn’t been proven and cut the fine by $117 million Wednesday.

Read more